In the last three months, 7 analysts have published ratings on Huntsman (NYSE:HUN), offering a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 0 | 4 | 2 | 1 |
| Last 30D | 0 | 0 | 0 | 1 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 3 | 0 | 0 |
| 3M Ago | 0 | 0 | 1 | 1 | 1 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $10.57, a high estimate of $13.00, and a low estimate of $8.00. This upward trend is apparent, with the current average reflecting a 20.25% increase from the previous average price target of $8.79.
Understanding Analyst Ratings: A Comprehensive Breakdown
An in-depth analysis of recent analyst actions unveils how financial experts perceive Huntsman. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| John Roberts | Mizuho | Raises | Underperform | $9.00 | $8.00 |
| Arun Viswanathan | RBC Capital | Raises | Sector Perform | $13.00 | $10.00 |
| Patrick Cunningham | Citigroup | Raises | Neutral | $12.00 | $10.50 |
| Joshua Spector | UBS | Raises | Neutral | $12.00 | $9.00 |
| John Roberts | Mizuho | Raises | Underperform | $8.00 | $7.00 |
| Duffy Fischer | Goldman Sachs | Raises | Sell | $9.50 | $8.50 |
| Patrick Cunningham | Citigroup | Raises | Neutral | $10.50 | $8.50 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Huntsman. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Huntsman compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Huntsman's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Huntsman's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on Huntsman analyst ratings.
Unveiling the Story Behind Huntsman
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.
Huntsman: Delving into Financials
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Challenges: Huntsman's revenue growth over 3M faced difficulties. As of 30 September, 2025, the company experienced a decline of approximately -5.19%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Huntsman's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -1.71%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Huntsman's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -0.89%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Huntsman's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -0.35%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Huntsman's debt-to-equity ratio is below the industry average. With a ratio of 0.87, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Analyst Ratings: What Are They?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
- No comments yet. Be the first to comment!